Novartis AG (NVSEF)
150.12
+0.31
(+0.21%)
USD |
OTCM |
Oct 26, 16:00
Novartis Market Cap : 274.80B for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 274.80B |
| October 23, 2026 | 274.23B |
| October 22, 2026 | 267.59B |
| October 21, 2026 | 267.59B |
| October 20, 2026 | 268.09B |
| October 19, 2026 | 268.09B |
| October 16, 2026 | 263.42B |
| October 15, 2026 | 264.18B |
| October 14, 2026 | 252.25B |
| October 13, 2026 | 252.25B |
| October 12, 2026 | 262.10B |
| October 09, 2026 | 256.24B |
| October 08, 2026 | 248.50B |
| October 07, 2026 | 245.70B |
| October 06, 2026 | 245.70B |
| October 05, 2026 | 246.26B |
| October 02, 2026 | 245.66B |
| October 01, 2026 | 257.98B |
| September 30, 2026 | 257.98B |
| September 29, 2026 | 265.31B |
| September 28, 2026 | 267.26B |
| September 25, 2026 | 258.03B |
| September 24, 2026 | 260.87B |
| September 23, 2026 | 253.31B |
| September 22, 2026 | 253.31B |
| Date | Value |
|---|---|
| September 21, 2026 | 253.08B |
| September 18, 2026 | 244.74B |
| September 17, 2026 | 260.05B |
| September 16, 2026 | 260.05B |
| September 15, 2026 | 260.05B |
| September 14, 2026 | 246.67B |
| September 11, 2026 | 252.19B |
| September 10, 2026 | 252.52B |
| September 09, 2026 | 253.53B |
| September 08, 2026 | 300.67B |
| September 04, 2026 | 300.67B |
| September 03, 2026 | 300.67B |
| September 02, 2026 | 287.02B |
| September 01, 2026 | 296.72B |
| August 31, 2026 | 265.45B |
| August 28, 2026 | 299.48B |
| August 27, 2026 | 299.48B |
| August 26, 2026 | 299.48B |
| August 25, 2026 | 299.48B |
| August 24, 2026 | 299.48B |
| August 21, 2026 | 288.51B |
| August 20, 2026 | 288.51B |
| August 19, 2026 | 292.89B |
| August 18, 2026 | 274.09B |
| August 17, 2026 | 267.14B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 331.13B |
| Addex Therapeutics Ltd. | 3.079M |
| Oculis Holding AG | 491.39M |
| Sandoz Group AG | 43.13B |
| Galderma Group AG | 53.81B |
Market Cap Related Metrics
| PE Ratio | 22.66 |
| PS Ratio | 5.276 |
| Price to Book Value | 6.615 |
| Price to Free Cash Flow | 19.04 |
| Price | 150.12 |
| Earnings Yield | 4.41% |
| Operating PE Ratio | 17.84 |
| Normalized PE Ratio | 21.11 |